Literature DB >> 16938018

Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

M Cotelli1, B Borroni, R Manenti, A Alberici, M Calabria, C Agosti, A Arévalo, V Ginex, P Ortelli, G Binetti, O Zanetti, A Padovani, S F Cappa.   

Abstract

Action naming has been reported to be disproportionately impaired in comparison to object naming in patients with frontotemporal dementia (FTD). This finding has been attributed to the crucial role of frontal cortex in action naming. The investigation of object and action naming in the different subtypes of FTD, as well as in the related conditions of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), may thus contribute to the elucidation of the cerebral correlates of the action-object discrepancy as well as provide clues to the underlying cognitive mechanisms. The results indicated that, with the exception of semantic dementia, action naming was more impaired than object naming in all patient groups. The discrepancy was similar in frontal variant of FTD and Alzheimer's disease patients, whereas patients with nonfluent primary progressive aphasia, PSP, and CBD were significantly more impaired in the oral production of actions than of objects. These findings indicate that action naming impairment is not a general feature of FTD, but rather is associated with conditions that affect the frontoparietal-subcortical circuits involved in action knowledge and action representation. ((c) 2006 APA, all rights reserved).

Entities:  

Mesh:

Year:  2006        PMID: 16938018     DOI: 10.1037/0894-4105.20.5.558

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  46 in total

Review 1.  Hearing and music in dementia.

Authors:  Julene K Johnson; Maggie L Chow
Journal:  Handb Clin Neurol       Date:  2015

2.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

3.  Covert processing of words and pictures in nonsemantic variants of primary progressive aphasia.

Authors:  Emily Rogalski; Alfred Rademaker; Marsel Mesulam; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Oct-Dec       Impact factor: 2.703

4.  Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Dana McDermott; Dan Luong; Christopher Randolph; Adam L Boxer
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-04       Impact factor: 2.475

5.  Neural representation of word categories is distinct in the temporal lobe: An activation likelihood analysis.

Authors:  Yasmeen Faroqi-Shah; Rajani Sebastian; Ashlyn Vander Woude
Journal:  Hum Brain Mapp       Date:  2018-08-18       Impact factor: 5.038

Review 6.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

7.  Are judgments for action verbs and point-light human actions equivalent?

Authors:  Christel Bidet-Ildei; Lucette Toussaint
Journal:  Cogn Process       Date:  2014-09-20

8.  Typical action perception and interpretation without motor simulation.

Authors:  Gilles Vannuscorps; Alfonso Caramazza
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

9.  Sound naming in neurodegenerative disease.

Authors:  Maggie L Chow; Simona M Brambati; Maria Luisa Gorno-Tempini; Bruce L Miller; Julene K Johnson
Journal:  Brain Cogn       Date:  2010-01-20       Impact factor: 2.310

10.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.